Open-label PTH(1-84) ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
235Hypoparathyroidism1

235. Hypoparathyroidism


Clinical trials : 88 Drugs : 128 - (DrugBank : 25) / Drug target genes : 5 - Drug target pathways : 7
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01199614
(ClinicalTrials.gov)
December 20099/9/2010HEXT (Hypo EXTended): Effect of PTH on Skeleton in HypoparathyroidismHEXT: The Hypoparathyroidism Studies, EXTended: The Effect of PTH on the Skeleton in HypoparathyroidismHypoparathyroidismDrug: open-label PTH(1-84)John P. BilezikianNPS Pharma;ShireActive, not recruiting18 Years85 YearsAll75Phase 3United States